Pfizer Ltd. - Research Center
500680 PFIZER Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | Mar ' 15 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 2,965.59 | 2,637.45 | 2,373.13 | 2,117.75 | 1,927.26 |
| Loan funds | |||||
| Secured loans | 2.50 | 2.50 | 2.50 | - | - |
| Unsecured loans | - | - | - | 2.50 | 2.50 |
| Total | 3,013.84 | 2,685.70 | 2,421.38 | 2,166.00 | 1,975.51 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 946.23 | 687.27 | 676.62 | 974.42 | 1,071.14 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 60.04 | 44.56 | 30.75 | 13.05 | 126.80 |
| Net block | 886.19 | 642.71 | 645.87 | 961.37 | 944.34 |
| Capital work-in-progress | - | 308.65 | 260.24 | 3.27 | 12.56 |
| Investments | - | - | - | - | 42.66 |
| Net current assets | |||||
| Current assets, loans & advances | 3,053.80 | 2,738.60 | 2,354.85 | 1,923.41 | 1,611.99 |
| Less : current liabilities & provisions | 926.15 | 1,004.26 | 839.58 | 722.05 | 636.03 |
| Total net current assets | 2,127.65 | 1,734.34 | 1,515.27 | 1,201.36 | 975.95 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 3,013.84 | 2,685.70 | 2,421.38 | 2,166.00 | 1,975.51 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | 42.66 |
| Market value of quoted investments | - | - | - | 0.08 | - |
| Contingent liabilities | 219.12 | 471.89 | 498.58 | 689.38 | 454.58 |
| Number of equity sharesoutstanding (Lacs) | 457.48 | 457.48 | 457.48 | 457.48 | 457.48 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis